Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03764748 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Washed Microbiota Transplantation for Tourette's Syndrome

Study acronym: WMT
StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Phase: Phase 1/2 to Phase 1v3 Show 11 more changesShow less
    • Lead sponsor: Faming Zhang to The Second Hospital of Nanjing Medical University
    • Primary and study completion dates: Oct 31, 2020 to Oct 31, 2027
    • Start date: Apr 17, 2017 to Apr 17, 2024
    • Primary endpoint revised
    • Interventions: mini-FMT (Drug) to Washed Microbiota Transplantation (Drug)
    • Eligibility criteria expanded, about 78 words
    • Secondary endpoints: 3 to 6
    • Study description shortened, about 43 words
    • Study sites revised (2)
    • Study title revised
    • Collaborators expanded, about 3 words
  2. Start date changed from estimate of Dec 1, 2018 to Apr 17, 2017v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aimed to evaluate the efficacy of washed microbiota transplantation in the treatment of Tourette's syndrome (TS).
Trial Details
NCT Number NCT03764748
Lead Sponsor The Second Hospital of Nanjing Medical University
Collaborators: Nanjing Medical University
Conditions
(from sponsor)		 Tourette Syndrome
Related terms Tic Disorders, Tourette Syndrome
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov